Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115173) titled 'Clinical intervention and follow-up study of atrial fibrillation combined with preserved ejection fraction heart failure patients' on Dec. 23, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Renmin Hospital of Wuhan University
Condition:
Atrial Fibrillation Combined with Heart Failure with Preserved Ejection Fraction
Intervention:
Trial group:Administer empagliflozin 10mg/day
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2024-04-05
Target Sample Size: Trial group:150;Control group:150;
Countries of Recruitment:
China
To know more, visit htt...